Centiva Capital’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,612
Closed -$252K 1499
2024
Q4
$252K Sell
3,612
-17,302
-83% -$1.44M 0.01% 1238
2024
Q3
$2.19M Buy
+20,914
New +$2.45M 0.04% 413
2024
Q2
Sell
-14,079
Closed -$1.57M 2020
2024
Q1
$1.57M Sell
14,079
-3,227
-19% -$385K 0.04% 429
2023
Q4
$2.24M Buy
17,306
+9,891
+133% +$1.36M 0.05% 320
2023
Q3
$1.21M Buy
7,415
+5,915
+394% +$1.04M 0.03% 547
2023
Q2
$275K Buy
+1,500
New +$216K 0.01% 1162
2022
Q4
Sell
-5,236
Closed -$317K 1335
2022
Q3
$317K Buy
+5,236
New +$338K 0.01% 1025
2022
Q2
Sell
-2,705
Closed -$204K 1645
2022
Q1
$204K Buy
+2,705
New +$185K ﹤0.01% 1284

Other funds holding ACLS

Centiva Capital's ACLS Position: Q1 2025 in Review

Centiva Capital sold out of Axcelis (ACLS) in Q1 2025, closing a stake of 3,612 shares — an estimated $252K sold.

Centiva Capital first reported a position in ACLS in Q1 2022 and held it in 8 quarters. The position peaked at $2.24M in Q4 2023. 306 funds tracked by Wall St. Rank hold ACLS as of Q1 2025.

  • Centiva Capital reported no remaining Axcelis position as of Q1 2025 after selling out during the quarter.
  • Centiva Capital sold 3,612 Axcelis shares in Q1 2025, an estimated $252K.
  • Centiva Capital first reported a position in Axcelis in Q1 2022 and held it in 8 quarters.
  • Centiva Capital's Axcelis position peaked at $2.24M in Q4 2023.
  • 306 funds tracked by Wall St. Rank held Axcelis as of Q1 2025.

Based on Centiva Capital's 13F filing for Q1 2025, filed 15 May 2025.